BioCentury
ARTICLE | Company News

Immunovo, Pepscan Therapeutics deal

May 10, 2010 7:00 AM UTC

Pepscan granted Immunovo an exclusive, worldwide license to develop and commercialize its vaccine portfolio for an undisclosed cash sum and a "significant minority" stake in Immunovo. Pepscan said the...